> "They asked for my availability and I said yes. When you decide to be a doctor in life, you get involved. I swore an oath. Afraid of getting sick? Then it is better not to be a doctor." March 2020
>
> -- Dr Giampiero Giron, 85 years old
>
> -- Professor emeritus, University of Padua

INTRODUCTION
============

This quote from Dr Giampiero Giron, an 85-year-old Italian anesthetist and member of the team that performed Italy's first heart transplant, encapsulates the commitment of doctors in difficult times and also the importance of older adults in our societies. On March 13th, 2020, the World Health Organization (WHO) effectively established that Europe is the new the COVID-19 pandemic epicenter of the world, as cases in Italy and other nations on the continent soared. As of March 26th 2020, across the world, cases reached over 500,000 and deaths reached 23,000.^([@b1-cgj-23-155])^ This dramatic and exponential increase in the prevalence and deaths related to COVID-19 is spreading rapidly through Europe, as it is now reporting more cases and deaths than the rest of the world combined.

Specifically, the numbers in Italy have climbed, with over 80,000 cases and 8,000 deaths as of March 26th, 2020, placing Italy now as the country with the highest mortality rate^([@b1-cgj-23-155])^ Importantly, older adults are particularly vulnerable to get severe illness and complications from this disease, and they also have a higher mortality rate than any other age group. The case fatality rate in Italy jumped from the 0.8% in those 50 to 59 years of age, to 2.7% in those 60 to 69 years of age, and to 21.1% in those 90 years and older ([Table 1](#t1-cgj-23-155){ref-type="table"}). Dr Matteo Cesari, Professor and Chair of Geriatric Medicine of the University of Milan, replied to our questions on March 26th, 2020, which are transcribed below.

Current Situation in Italy
--------------------------

**MMO:** Thank you, Matteo, for making this time for our questions. We know you are under extreme pressure and busy with unprecedented clinical demands, therefore we appreciate you providing us with direct information. How is the situation in Lombardy and, specifically, Milan, now (March 25, 2020)?

**MC:** The situation in Milan is still very complicated. We have not yet reached the peak of the number of new COVID cases, which is expected to arrive in the very next few days.

[Figure 1](#f1-cgj-23-155){ref-type="fig"} shows the distribution of cases among Italian regions, and it can be seen how the north of Italy took the first hit. The hospitals have been struggling since the beginning of the crisis because they needed to substantially redraw their pathways in an attempt to isolate COVID-positive patients from the others. At the same time, the system was not ready to sustain the massive number of patients with respiratory symptoms arriving all together at the emergency departments.

As we can see in [Figure 2](#f2-cgj-23-155){ref-type="fig"}, 25% of our patients presented with severe disease and 5% are critical, all of them require hospitalization. This, combined with the shortage of ICU beds and the gradual decrease in health-care professionals that were falling sick, has made things extremely difficult.

**MMO:** How is the clinical presentation of the symptomatic disease in older adults? Have you found any differences when compared with younger adults? Do older patients with severe COVID-19 illness present with severe dyspnea and hypoxemia, as do the younger adults? Or do older patients present with geriatric syndromes, such as delirium?

**MC:** The clinical manifestation is usually characterized by fever and cough. It might appear as a normal pneumonia. In fact, very frequently, the COVID-19 case manifests itself as a pneumonia resistant to antibiotics and standard care. The worsening of respiratory symptoms is today considered a clear sign suggestive of COVID infection. Since the very beginning, we have tried as much as possible to isolate patients with respiratory symptoms or flu-like manifestations from the others, given the high contagiousness of the coronavirus. This was also to allow the time to test for the possible SARS-CoV-2 infection. In this context, however, things are made difficult by the relatively high number of false--negative cases found from the nasopharyngeal swab. For this reason, people tend to be kept isolated even when tested negative, if the clinical suspicion remains high.

Overall, the Istituto Superiore di Sanitá (ISS) from Italy reports that the most common complications are the following: acute respiratory distress syndrome (97.5% of cases), acute renal failure (28.9%), acute cardiac injury (11.2%), and superinfection (10.2%). Nevertheless, the clinical manifestation of the COVID in older persons can be associated with delirium. The main difference is the unexpectedly rapid course of the disease. Many patients convert in 20--30 min from relatively stable conditions into severe respiratory distress. In other words, preliminary signs can be there, but their identification and management is often impossible given the quick evolution of the case.

It is also noteworthy that hospitals have relatively few geriatricians, and they had to reorganize their workforces creating mixed teams. This was needed to face the shortage of personnel. I have to say that, in this emergency situation, it is very difficult for non-specialized clinicians to pay attention and detect geriatric syndromes that are largely overlooked and underestimated even in normal times.

Current Situation in Hospital Settings
--------------------------------------

**MMO:** How are access to Emergency Room (ER) care, inpatient beds, and critical care beds being managed? There have been reports in the media that older citizens should get a lower priority for access to medical services that are now limited, such as intensive care facilities and ventilation. This begs the question of whether this practice should go unchallenged as a form of "pragmatism", or whether we should think through how to engage with this in order to at least reduce the risk of the most egregious forms of discrimination.

**MC:** ERs have been exponentially overwhelmed over the past weeks. The shortage of beds, especially in ICUs, has sometimes led to very difficult decisions. The relatively few number of ventilators, in fact, has generated discussions about the ethics of procedures applied to certain patients. The Italian Society of Analgesia, Anaesthesia, Resuscitation, and Intensive Care (SIAARTI) released a document recommending a triage in a low-resource scenario based on age, comorbidities, and functional status.^([@b2-cgj-23-155])^ Unfortunately, the ageistic approach diffused in our society and in traditional medicine, as well as the poor knowledge about how to operationally apply these recommendations, makes critical decisions still (too largely) governed by the age criterion. I do not/cannot justify these decisions, but we also need to consider that the rapid course of the disease leads to taking quite rapid decisions.

**MMO:** Related to the previous question, in the stratification or triage of sick patients to maximize health resources, do you use a functional scale, or frailty status scale, or dementia severity scale for clinical decisions?

**MC:** Age of the patient itself has been the easiest parameter to obtain in an emergency to decide on allocation of care. It is wrong and we know it. Unfortunately, our system does not yet consider more robust and reliable alternatives for measuring the resilience of the person. Perhaps, we should have thought about nesting more geriatric principles (i.e., meaning of the disease construct at old age, importance of functions) in other specialties. The simple adoption of the Clinical Frailty Scale measuring the pre-illness status of the patient might have already represented an important parameter in order to take better decisions.^([@b3-cgj-23-155]--[@b5-cgj-23-155])^

**MMO:** How does a COVID unit look like in Italy for geriatricians?

**MC:** A COVID unit is very far from our usual geriatric world. The communication between health-care professionals and patients is extremely limited by the personal protective equipment (PPE), as well as by the patient's clinical conditions and respiratory devices. The unit environment is not age-friendly; its design is not oriented to individuals with sensory deficits or cognitive and/or mobility impairment. These units are busy, noisy, and only distinguish the "dirty" areas from the "clean" ones. Family members are not allowed to enter the unit. Therefore, patients have no contact with them, and family members are usually not receiving news of their relatives. For this reason, we have volunteers who are regularly keeping families updated about the status of the patients over the phone. We try to maintain such contacts, knowing that the worst thing happening with COVID is the isolation of the person.

The Situation in Long-term Care Facilities
------------------------------------------

**MMO:** How is the situation in long-term care facilities? Do you have any recommendations to provide---particularly in this setting?

**MC:** Long term facilities have initially tried to contain the diffusion of the virus within their facilities by reducing/closing admissions from the hospitals. Suspected cases have been isolated and/or sent to the emergency units in order to guarantee the safety of the rest of the residents. The work in long-term care is not easy these days, also because resources to test patients (and personnel) remain limited. There have also been limitations in some cases of protected personal equipment's (PPEs). Just in these last few days, the WHO has released recommendations for the management of COVID in long term care. (<https://apps.who.int/iris/bitstream/handle/10665/331508/WHO-2019-nCoV-IPC_long_term_care-2020.1-eng.pdf>)^([@b6-cgj-23-155])^

Medication Access for Older Adults
----------------------------------

**MMO:** As many older adults suffer from chronic conditions requiring medication, the question of how medication access is being managed is of paramount importance. How are you managing medication access to older patients with chronic conditions?

**MC:** Outpatient clinics were closed at the very beginning of the coronavirus outbreak. Only visits that could not be postponed or that met urgency criteria were maintained. A lot of older persons have found themselves completely isolated from medications, but also from the simple access to groceries. In this scenario, consider that general practitioners have found themselves in huge difficulties (shortage of PPEs, a lot of cases of COVID, some even died). The consequent shortage of primary care physicians has further complicated things.

Frail older persons with chronic diseases will likely pay a huge toll for this coronavirus pandemic, even if not directly infected by it. This emergency situation has destroyed our already weak integration of care services, critical for the health of frail individuals.

Potential Explanations for the Higher Prevalence and Severity of the COVID-19 Crisis in Older Adults
----------------------------------------------------------------------------------------------------

**MMO:** An additional fact is that the case mortality rate is higher in older adults, but particularly in those with cardiovascular disease, hypertension, and diabetes or having more than three comorbidities ([Table 2](#t2-cgj-23-155){ref-type="table"}). It has been suggested that Angiotensin-converting enzyme 2 (ACE-2) inhibitors may explain the higher risk and severity of the disease in older adults^([@b7-cgj-23-155])^ because they increase the up-regulation of ACE-2 receptor expression---the receptor that the SARS CoV-2 virus uses to enter the human cells.^([@b7-cgj-23-155])^ Are clinicians changing the ACE-2 inhibitor medication in their patients for another medication such as calcium channel blockers?

**MC:** There have been many news items around about the positive or negative effects of certain medications in face of the COVID. To my knowledge, most of the clinicians have not changed the prescriptions of cardiovascular drugs of their patients, also given the recommendations from the American Heart Association, the Heart Failure Society of America, and the American College of Cardiology. Another news item was related to a possible association of ibuprofen to negative outcomes in COVID cases. This led to the suggestion of using paracetamol over ibuprofen. In this other case, the WHO explained that the news was not supported by evidence and discouraged the non-utilization of ibuprofen.

**MMO:** Is there something else that you want to add?

**MC:** Thank you, Manuel, for reaching out and I hope our experience will help Canadian geriatricians and health-care workers dealing with older adults during this overwhelming pandemic. We are in uncharted territory.

KEY POINTS
==========

1.  Older adults present the highest mortality rate in this pandemic, in the Italian epicenter and worldwide.

2.  Clinical presentation in older adults with severe illness is quite sudden; patients can develop severe hypoxemia and need ventilation support in very few hours.

3.  Geriatric syndromes are overlooked as a form of presentation of COVID-19 severe illness, being this dominated by severe respiratory symptoms.

4.  Stratification by frailty level may help to early detect the most vulnerable.

5.  Decision concerning health-care utilization resources should not be taken based only on age itself or isolated diagnoses, such as the presence of dementia; rather, advanced directives or functional/frailty stratification may be considered.
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###### 

Istituto Svperiore di Sanitá (ISS) data on cases that tested positive for SARS-COV-2 infection diagnosed by all Italian Regions/Autonomous Provinces

  *Age (years)*   *Deaths (n (%)\]*   *Case Fatality Rate (CFR)*
  --------------- ------------------- ----------------------------
  0--9            0 (0%)              0%
  10--19          0 (0%)              0%
  20--29          0 (0%)              0%
  30--39          2 (0.2%)            0.2%
  40--49          4 (0.4%)            0.2%
  50--59          24 (2.4%)           0.8%
  60--69          77 (7.6%)           2.7%
  70--79          360 (35.4%)         10.8%
  80--89          438 (43.0%)         17.5%
  \>90            96 (9.4%)           21.1%
  Not reported    16 (1.6%)           2.8%
  Total           1,017 (100%)        6.2%

###### 

Most common comorbidities observed in COVID-19--positive deceased patients by type of disease[a](#tfn1-cgj-23-155){ref-type="table-fn"}

  *Disease*                           *N*   *%*
  ----------------------------------- ----- ------
  Ischemic heart disease              126   24.5
  Atrial fibrillation                 121   23.5
  Stroke                              64    12.5
  Hypertension                        384   74.7
  Diabetes                            157   30.5
  Dementia                            90    17.5
  COPD                                98    19.1
  Active cancer in the past 5 years   92    17.9
  Chronic liver disease               25    4.9
  Chronic renal failure               119   23.2
                                            
  *Number of Comorbidities*                 
                                            
  0 comorbidities                     7     1.4
  1 comorbidities                     110   21.4
  2 comorbidities                     134   26.1
  3 comorbidities and over            263   51.2

Data on diseases were based on chart review and was available on 514 patients dying in-hospital for whom it was possible to analyze clinic charts (15.0% of the sample). Mean number of diseases was 2.7 (median 3, SD 1.6). Overall, 1.4% of the sample presented with no comorbidities, 21.4% with a single comorbidity, 26.1% with 2, and 51.2% with 3 or more.
